AIGH Capital Management
Latest statistics and disclosures from AIGH Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IWM, SNDK, ZM, XLK, TYGO, and represent 54.47% of AIGH Capital Management's stock portfolio.
- Added to shares of these 10 stocks: IWM (+$149M), ZM (+$56M), XLK (+$40M), TYGO (+$27M), SIMO (+$23M), ZBRA (+$21M), GNRC (+$18M), APPS (+$14M), RRX (+$14M), ZVRA (+$11M).
- Started 18 new stock positions in ZM, VUZI, INVE, APPS, WATT, BDSX, GNRC, XLK, RRX, ZVRA. TYGO, ZBRA, RGNT, TARA, IWM, VSTM, SIMO, LPCN.
- Reduced shares in these 10 stocks: Zoom Video Communications In call (-$60M), SNDK (-$51M), DAWN (-$19M), DOMO (-$16M), LASR (-$15M), BKTI (-$13M), LPTH (-$9.3M), Kempharm (-$9.0M), ARQ (-$7.4M), ARDX (-$6.7M).
- Sold out of its positions in GRCE, ARQ, ARDX, BYRN, DAWN, DOMO, Kempharm, Zoom Video Communications In call, Seagate Technology Hldngs Pl.
- AIGH Capital Management was a net buyer of stock by $225M.
- AIGH Capital Management has $733M in assets under management (AUM), dropping by 78.03%.
- Central Index Key (CIK): 0001835943
Tip: Access up to 7 years of quarterly data
Positions held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for AIGH Capital Management
AIGH Capital Management holds 43 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 20.3 | $149M | NEW | 600k | 248.00 |
|
| Sandisk Corp (SNDK) | 17.3 | $127M | -28% | 200k | 635.34 |
|
| Zoom Communications Cl A Call Option (ZM) | 7.7 | $56M | NEW | 700k | 80.39 |
|
| Select Sector Spdr Tr State Street Tec Put Option (XLK) | 5.4 | $40M | NEW | 300k | 132.90 |
|
| Tigo Energy (TYGO) | 3.7 | $27M | NEW | 7.3M | 3.76 |
|
| Silicon Motion Technology Sponsored Adr (SIMO) | 3.1 | $23M | NEW | 200k | 112.29 |
|
| Zebra Technologies Corporati Cl A (ZBRA) | 2.9 | $21M | NEW | 100k | 209.08 |
|
| Nlight (LASR) | 2.6 | $19M | -43% | 340k | 57.02 |
|
| Vanda Pharmaceuticals (VNDA) | 2.6 | $19M | +37% | 2.8M | 6.91 |
|
| Personalis Ord (PSNL) | 2.5 | $19M | 2.9M | 6.37 |
|
|
| Generac Holdings (GNRC) | 2.4 | $18M | NEW | 90k | 195.33 |
|
| Kyverna Therapeutics (KYTX) | 2.4 | $17M | +33% | 2.0M | 8.63 |
|
| Castle Biosciences (CSTL) | 2.0 | $15M | -5% | 591k | 24.55 |
|
| Digital Turbine Com New (APPS) | 1.9 | $14M | NEW | 4.9M | 2.88 |
|
| Regal-beloit Corporation (RRX) | 1.9 | $14M | NEW | 75k | 187.26 |
|
| Abeona Therapeutics Com New (ABEO) | 1.9 | $14M | +55% | 3.1M | 4.48 |
|
| Larimar Therapeutics (LRMR) | 1.8 | $14M | +50% | 3.0M | 4.50 |
|
| Fennec Pharmaceuticals (FENC) | 1.7 | $12M | +25% | 2.0M | 6.15 |
|
| Esperion Therapeutics (ESPR) | 1.6 | $12M | +10% | 4.4M | 2.74 |
|
| Zevra Therapeutics Com New (ZVRA) | 1.5 | $11M | NEW | 1.2M | 9.32 |
|
| Biodesix (BDSX) | 1.5 | $11M | NEW | 758k | 14.50 |
|
| Intellicheck Mobilisa Com New (IDN) | 1.4 | $11M | +25% | 1.5M | 6.99 |
|
| Verastem Com New (VSTM) | 1.4 | $11M | NEW | 2.0M | 5.30 |
|
| Protara Therapeutics Com Stk (TARA) | 1.2 | $8.5M | NEW | 1.6M | 5.21 |
|
| Vuzix Corp Com New (VUZI) | 1.0 | $7.6M | NEW | 3.3M | 2.31 |
|
| Polypid (PYPD) | 1.0 | $7.0M | +18% | 1.6M | 4.38 |
|
| Apyx Medical Corporation (APYX) | 0.6 | $4.1M | 1.1M | 3.69 |
|
|
| Coya Therapeutics Common Stock (COYA) | 0.5 | $3.8M | 975k | 3.94 |
|
|
| Elutia Cl A Com (ELUT) | 0.5 | $3.8M | +17% | 3.6M | 1.05 |
|
| Renovorx Com New (RNXT) | 0.5 | $3.7M | +30% | 3.7M | 1.01 |
|
| Talphera Com New (TLPH) | 0.5 | $3.5M | 4.7M | 0.75 |
|
|
| Energous Corp Com New (WATT) | 0.5 | $3.4M | NEW | 215k | 15.69 |
|
| Ideal Pwr Com New (IPWR) | 0.5 | $3.3M | +140% | 1.2M | 2.83 |
|
| Neuraxis (NRXS) | 0.4 | $3.0M | 400k | 7.40 |
|
|
| Bk Technologies Corporation Com New (BKTI) | 0.3 | $2.4M | -84% | 33k | 74.63 |
|
| Lipocine Com New (LPCN) | 0.2 | $1.6M | NEW | 200k | 7.99 |
|
| Identiv Com New (INVE) | 0.2 | $1.5M | NEW | 409k | 3.70 |
|
| Lightpath Technologies Com Cl A (LPTH) | 0.1 | $1.0M | -90% | 100k | 10.03 |
|
| Regentis Biomaterials Ordinary Shares (RGNT) | 0.1 | $917k | NEW | 300k | 3.06 |
|
| Aprea Therapeutics Com New (APRE) | 0.1 | $775k | +174% | 1.0M | 0.76 |
|
| Biofrontera Com New (BFRI) | 0.1 | $740k | 915k | 0.81 |
|
|
| Quoin Pharmaceuticals Sponsored Ads (QNRX) | 0.0 | $337k | +3% | 51k | 6.60 |
|
| Smartkem Com New (SMTK) | 0.0 | $204k | +32% | 895k | 0.23 |
|
Past Filings by AIGH Capital Management
SEC 13F filings are viewable for AIGH Capital Management going back to 2020
- AIGH Capital Management 2026 Q1 filed April 30, 2026
- AIGH Capital Management 2025 Q4 filed Feb. 2, 2026
- AIGH Capital Management 2025 Q3 filed Oct. 31, 2025
- AIGH Capital Management 2025 Q2 filed July 29, 2025
- AIGH Capital Management 2025 Q1 filed May 6, 2025
- AIGH Capital Management 2024 Q4 filed Feb. 12, 2025
- AIGH Capital Management 2024 Q3 filed Nov. 13, 2024
- AIGH Capital Management 2024 Q2 filed Aug. 7, 2024
- AIGH Capital Management 2024 Q1 filed May 14, 2024
- AIGH Capital Management 2023 Q4 filed Feb. 12, 2024
- AIGH Capital Management 2023 Q3 filed Nov. 13, 2023
- AIGH Capital Management 2023 Q2 filed Aug. 14, 2023
- AIGH Capital Management 2023 Q1 filed May 15, 2023
- AIGH Capital Management 2022 Q4 filed Feb. 15, 2023
- AIGH Capital Management 2022 Q3 filed Nov. 14, 2022
- AIGH Capital Management 2022 Q2 filed Aug. 12, 2022